TWINRIX
NDC 50090-1645, Hepatitis A and Hepatitis B (Recombinant) Vaccine, injection, suspension, from A-S Medication Solutions.
- Product NDC
- 50090-1645
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103850
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-1645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)720 [iU]/mL
- HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN20 ug/mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Hepatitis A Vaccines [CS]; Inactivated Hepatitis A Virus Vaccine [EPC]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-1645-0 | 50090164500 | 10 SYRINGE in 1 CARTON (50090-1645-0) / 1 mL in 1 SYRINGE (50090-1645-9) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50090-1645 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-1645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-1645. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.